NCT04617184 Registry and Biorepository for IBD in Central Texas
| NCT ID | NCT04617184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas at Austin |
| Condition | Crohn Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-06-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-06-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.
Eligibility Criteria
Inclusion Criteria: * Male or female, age 18 years or older * Willing and able to provide written consent for participation in the registry and biorepository * Patients with known or suspected inflammatory bowel disease Exclusion Criteria: * Patient is unable to comprehend and/or cooperate with study activities * Patient is too ill to provide consent * Coagulopathy that precludes safe biopsy of the bowel * Comorbidity that precludes safe participation in endoscopic procedures
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04617184 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Crohn Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04617184 currently recruiting?
Yes, NCT04617184 is actively recruiting participants. Contact the research team at benjamin.chebaa@austin.utexas.edu for enrollment information.
Where is the NCT04617184 trial being conducted?
This trial is being conducted at Austin, United States.
Who is sponsoring the NCT04617184 clinical trial?
NCT04617184 is sponsored by University of Texas at Austin. The trial plans to enroll 1,000 participants.